We’re excited to introduce our GLP-standard intracranial dosing platform delivering targeted compounds directly to the brain for more precise CNS preclinical studies. ✅ Bypasses the blood-brain barrier ✅ Reduces systemic side effects ✅ Enhances translational relevance Now fully GLP-validated with: Documented SOPs & equipment Verified dose placement MHRA-audited compliance 📈 Benefits: Regulatory-ready data, better reproducibility, and lower repeat study costs. 👉 Swipe the carousel to learn more. 🔗 www.pharmidex.com

We’re excited to share our latest work on tumour microdialysis, a powerful technique for measuring unbound, pharmacologically active drug concentrations directly within brain tumours like glioblastoma. Unlike systemic plasma levels, microdialysis provides a true picture of drug penetration into the tumour helping to uncover heterogeneous distribution and the impact of the blood-tumour barrier. Our approach involves precise stereotaxic surgery, tumour validation, and sampling from both tumour and healthy brain tissue enabling direct, comparative pharmacokinetic analysis. 📊 The results? Significant differences in drug exposure between tumour core and surrounding tissue. 👉 Swipe through the carousel to explore our process and findings.  🔗 www.pharmidex.com